Komori
KYORIN Pharmaceutical (4569) · RiskDropped

Weak Economic Conditions and Consumer Spending

First written in FY2017-Q1. 1 of 5 entries say "Softened", first in FY2017-Q2. Latest entry: FY2019.

5entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20192016: 220162017: 220172018: 020182019: 12019
Same theme, other companies
Uncertainty surrounding domestic and overseas economic and demand conditionsA theme 289 companies write about · 296 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2022: 131 of 176 companies on the "Worse" side.

1 other company's latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 296 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2019DroppedAnnual report

    「During the fiscal year, the domestic pharmaceutical industry was operating amid the promotion of various measures to improve the efficiency of medical and pharmaceutical costs against the backdrop of securing funding for social security expenses,」

    The previously described weakness in the economy and consumer spending is not repeated in this filing's description of the business environment.
  2. FY2017RestatedAnnual report

    「The environment surrounding the healthcare business remained uncertain, with the economy showing a moderate recovery but consumer spending remaining flat, and uncertainty still not dispelled.」

    It describes the economic recovery, flat consumer spending and continued uncertainty.
  3. FY2017-Q3WorsenedAnnual report

    「The environment surrounding the healthcare business remained uncertain, with the economy showing a moderate recovery but consumer spending remaining flat, and uncertainty still not dispelled.」

    While the economy recovered, the description of consumer spending weakened from improvement to a flat trend, and uncertainty also continues.
  4. FY2017-Q2SoftenedAnnual report

    「The environment surrounding the healthcare business remained uncertain, although consumer spending gradually improved and the economy showed a moderate recovery.」

    Consumer spending and the economy showed signs of improvement and recovery, easing some of their previous weakness, but uncertainty about the outlook remains.
  5. FY2017-Q1First statedAnnual report

    「The environment surrounding the healthcare business remained one in which economic conditions were broadly flat and consumer spending remained weak.」

    Stagnant economic conditions and weak consumer spending are described as external risks to the healthcare business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Weak Economic Conditions and Consumer Spending | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori